News & Media Catch up with our latest releases here. Filter Article 55 Podcast 3 Video 26 Article Rob Bennett 05/11/2024 Article Rob Bennett 05/11/2024 OCT announces exclusive Joint Development Agreement with ex- Google AI experts, Hypatia AI to develop an AI-enabled asset toscale its drug discovery pipeline Read More Article Rob Bennett 19/09/2024 Article Rob Bennett 19/09/2024 The Science behind OCT Read More Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 16/07 Cannabinoid Research and Development Group (CRDG) inaugural report launch Read More Rita Ray 16/08/2024 Rita Ray 16/08/2024 10/07 Our CEO, Clarissa Sowemimo-Coker speaking at HLTH Europe 2024 Video interview Read More Rita Ray 16/08/2024 Rita Ray 16/08/2024 28/06 We are hiring! Head of Drug Discovery and Development Read More Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 09/05 Oxford Cannabinoid Technologies De-List from the LSE To Pursue Private Funding To Accelerate Development Read More Article, Video Rob Bennett 16/08/2024 Article, Video Rob Bennett 16/08/2024 09/05 OCT Reveal Plans to Delist as Stocks Struggle Read More Rita Ray 16/08/2024 Rita Ray 16/08/2024 08/05 British Biotech OCTP shares (Oxford Cannabinoid) delisting from LSE Read More Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 08/05 British biotech joins LSE exodus Read More Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 08/05 Snoop Dogg cannabis firm to ditch London after losing 97% of its value Read More Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 08/05 A bad trip: Oxford Cannabinoid to delist from ‘turbulent’ London markets Read More Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 08/05 Snoop Dogg-backed cannabis biotech startup to quit ‘turbulent’ London stock market Read More Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 08/05 Oxford Cannabinoid to quit London market Read More Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 24/04 Joining OCT's innovative journey - Lord Mott OBE Read More Rita Ray 16/08/2024 Rita Ray 16/08/2024 15/04 Oxford Cannabinoid Technologies Appoint CRO en route to Phase I Trials for Programme Two Read More Rita Ray 14/08/2024 Rita Ray 14/08/2024 11/04 Appointment of Phase I Clinical Trial CRO Appointment of Phase I Clinical Trial CRO Read More Rita Ray 05/04/2024 Rita Ray 05/04/2024 OCT Company Update with Doceo OCT Company Update with Doceo Read More Rita Ray 05/04/2024 Rita Ray 05/04/2024 OCT’s Elevator Pitch with Doceo Read More Rita Ray 04/04/2024 Rita Ray 04/04/2024 The importance of patents Read More Rita Ray 04/04/2024 Rita Ray 04/04/2024 Cornerstone investor Cantheon is kudos for OCT Read More Older Posts
Article Rob Bennett 05/11/2024 Article Rob Bennett 05/11/2024 OCT announces exclusive Joint Development Agreement with ex- Google AI experts, Hypatia AI to develop an AI-enabled asset toscale its drug discovery pipeline Read More
Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 16/07 Cannabinoid Research and Development Group (CRDG) inaugural report launch Read More
Rita Ray 16/08/2024 Rita Ray 16/08/2024 10/07 Our CEO, Clarissa Sowemimo-Coker speaking at HLTH Europe 2024 Video interview Read More
Rita Ray 16/08/2024 Rita Ray 16/08/2024 28/06 We are hiring! Head of Drug Discovery and Development Read More
Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 09/05 Oxford Cannabinoid Technologies De-List from the LSE To Pursue Private Funding To Accelerate Development Read More
Article, Video Rob Bennett 16/08/2024 Article, Video Rob Bennett 16/08/2024 09/05 OCT Reveal Plans to Delist as Stocks Struggle Read More
Rita Ray 16/08/2024 Rita Ray 16/08/2024 08/05 British Biotech OCTP shares (Oxford Cannabinoid) delisting from LSE Read More
Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 08/05 British biotech joins LSE exodus Read More
Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 08/05 Snoop Dogg cannabis firm to ditch London after losing 97% of its value Read More
Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 08/05 A bad trip: Oxford Cannabinoid to delist from ‘turbulent’ London markets Read More
Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 08/05 Snoop Dogg-backed cannabis biotech startup to quit ‘turbulent’ London stock market Read More
Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 08/05 Oxford Cannabinoid to quit London market Read More
Article Rob Bennett 16/08/2024 Article Rob Bennett 16/08/2024 24/04 Joining OCT's innovative journey - Lord Mott OBE Read More
Rita Ray 16/08/2024 Rita Ray 16/08/2024 15/04 Oxford Cannabinoid Technologies Appoint CRO en route to Phase I Trials for Programme Two Read More
Rita Ray 14/08/2024 Rita Ray 14/08/2024 11/04 Appointment of Phase I Clinical Trial CRO Appointment of Phase I Clinical Trial CRO Read More
Rita Ray 05/04/2024 Rita Ray 05/04/2024 OCT Company Update with Doceo OCT Company Update with Doceo Read More
